127 identified primary dysfunctions of inserts in 13% of patients when biopsies had confirmed steatosis of greater than 30% compared to only 3% among those patients with no steatosis.
Desde 1991, Adam y cols 127 identificaron disfunción primaria del injerto del 13% cuando la biopsia confirmó esteatosis > 30% versus un 3% en injertos sin esteatosis.